Furthermore, a meta-analysis of multiple studies across various ethnic groups emphasizes that FTO’s role in breast cancer risk is often mediated by factors like obesity, estrogen receptor status, and metabolic health (42). This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.